Karuna Therapeutics
fund manager
sector
Healthcare
geography
North America
Vintages
status
Transfer
category
#Innovative

Karuna Therapeutics

Co-invested company
Karuna Therapeutics is a clinical trial-focused biopharmaceutical company focused on creating and delivering innovative medicines to people with psychiatric and neurological disorders.
Karuna Therapeutics joins Private Equity manager's portfolio General Atlantic

Key figures for Karuna Therapeutics

364 M$
spent on research in 2023
+ 300$
average Kahuna share price on Nasdaq
5
doctors on the executive committee
2009
year established
Data at
4/10/24
*Source: Public data from company websites and social networks. For the most up-to-date information, we invite our investors to consult the reports available in their own space.

About Karuna Therapeutics

Karuna Therapeutics is backed by in-depth expertise in neuroscience and a strong capacity for innovation in research and development.

Karuna is the Sanskrit word for compassion in action, to alleviate the suffering of others. This is the company's vision: to transform the treatment of mental illness in order to improve the lives of those so deserving of compassion.

Based in the U.S., the company is working on the development of drugs that can bring significant relief to patients suffering from psychiatric and neurological disorders, with a particular focus on schizophrenia and the behavioral symptoms associated with Alzheimer's disease.

In the same sector as Karuna Therapeutics

Company videos
No items found.
Discover our exclusive services
General Atlantic
Odyssey 2021
Odyssey 2021
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio